collection
https://read.qxmd.com/read/33039013/an-overview-of-seminal-plasma-hypersensitivity-and-approach-to-treatment
#1
REVIEW
William J Lavery, Margo Stevenson, Jonathan A Bernstein
Seminal plasma hypersensitivity (SPH) presents with localized vaginal and/or systemic allergic symptoms on exposure to protein components of seminal plasma. Although the true incidence is unclear, it is a likely underdiagnosed but an important cause of vulvovaginitis and dyspareunia that affects women across the entire globe. Systemic SPH is likely elicited by an IgE-mediated reaction to seminal plasma proteins other than spermatozoa. Localized reactions are likely mediated by a non-IgE immunologic mechanism...
October 2020: Journal of Allergy and Clinical Immunology in Practice
https://read.qxmd.com/read/30794967/anaphylaxis-to-hidden-pea-protein-a-canadian-pediatric-case-series
#2
LETTER
Elana Lavine, Moshe Ben-Shoshan
No abstract text is available yet for this article.
July 2019: Journal of Allergy and Clinical Immunology in Practice
https://read.qxmd.com/read/31476322/aaaai-mast-cell-disorders-committee-work-group-report-mast-cell-activation-syndrome-mcas-diagnosis-and-management
#3
JOURNAL ARTICLE
Catherine R Weiler, K Frank Austen, Cem Akin, Marla S Barkoff, Jonathan A Bernstein, Patrizia Bonadonna, Joseph H Butterfield, Melody Carter, Charity C Fox, Anne Maitland, Thanai Pongdee, S Shahzad Mustafa, Anupama Ravi, Mary C Tobin, Harissios Vliagoftis, Lawrence B Schwartz
Our current recommendations for diagnosing and treating primary mast cell (MC) activation syndrome make use of the latest studies and consensus guidelines for clinically recognizing systemic anaphylaxis in real time, regardless of whether allergen-triggered or other pathways are involved; our current understanding of the biomarkers secreted by activated MCs that best discriminate this disorder from other conditions; and the therapeutic drugs that might selectively affect those mediators or MCs themselves. Finding familial or somatic mutations of genes that cause MCs to be hyperactivatable would extend our diagnostic tools and potentially indicate new therapeutic interventions, targeting either the mutated gene product or the associated molecular pathway...
October 2019: Journal of Allergy and Clinical Immunology
https://read.qxmd.com/read/31513910/idiopathic-anaphylaxis-yardstick-practical-recommendations-for-clinical-practice
#4
JOURNAL ARTICLE
Melody C Carter, Cem Akin, Mariana C Castells, Erin P Scott, Phil Lieberman
Anaphylaxis is considered idiopathic when there is no known trigger. The signs and symptoms of idiopathic anaphylaxis (IA) are identical to those of anaphylaxis because of a known cause and can include cutaneous, circulatory, respiratory, gastrointestinal, and neurologic symptoms. Idiopathic anaphylaxis can be a frustrating disease for patients and health care providers. Episodes are unpredictable, and differential diagnosis is challenging. Current anaphylaxis guidelines have little specific guidance regarding differential diagnosis and long-term management of IA...
January 2020: Annals of Allergy, Asthma & Immunology
https://read.qxmd.com/read/31247266/advances-in-drug-allergy-urticaria-angioedema-and-anaphylaxis-in-2018
#5
REVIEW
Rachel L Miller, Maria Shtessel, Lacey B Robinson, Aleena Banerji
Many notable advances in drug allergy, urticaria, angioedema, and anaphylaxis were reported in 2018. Broad-spectrum antibiotic use and, consequently, antibiotic resistance are widespread, and algorithms to clarify β-lactam allergy and optimize antibiotic use were described. Meaningful data emerged on the pathogenesis of delayed drug hypersensitivity reactions. Progress not only in defining biomarkers but also in understanding the effect on quality of life and developing better treatments has been made for patients with chronic idiopathic urticaria...
August 2019: Journal of Allergy and Clinical Immunology
https://read.qxmd.com/read/30263034/anaphylaxis
#6
REVIEW
David Fischer, Timothy K Vander Leek, Anne K Ellis, Harold Kim
Anaphylaxis is an acute, potentially fatal systemic allergic reaction with varied mechanisms and clinical presentations. Although prompt recognition and treatment of anaphylaxis are imperative, both patients and healthcare professionals often fail to recognize and diagnose early signs and symptoms of the condition. Clinical manifestations vary widely; however, the most common signs are cutaneous symptoms, including urticaria, angioedema, erythema and pruritus. Immediate intramuscular administration of epinephrine into the anterolateral thigh is first-line therapy, even if the diagnosis is uncertain...
2018: Allergy, Asthma, and Clinical Immunology
https://read.qxmd.com/read/30324360/in-vivo-evaluation-of-taste-masked-fast-disintegrating-sublingual-tablets-of-epinephrine-microcrystals
#7
JOURNAL ARTICLE
Ousama Rachid, Keith J Simons, Mutasem Rawas-Qalaji
In community settings, IM injection of 0.3 mg epinephrine (Epi) using an auto-injector is the drug of choice for treatment of anaphylaxis. Previously, a taste-masking (TM) formulation of fast-disintegrating sublingual tablets (FDSTs) was developed in our lab. Also, Epi was micronized (Epi-MC) successfully and reduced the previously achieved bioequivalent sublingual Epi dose to 0.3 mg IM injection by half using non-taste-masked fast-disintegrating sublingual tablets (TM-FDSTs). Our objective for this study was to evaluate the sublingual absorption of Epi-MC using TM-FDST...
November 2018: AAPS PharmSciTech
https://read.qxmd.com/read/30048251/phenotypes-endotypes-and-biomarkers-in-anaphylaxis-current-insights
#8
REVIEW
Anna Sala-Cunill, Mar Guilarte, Victoria Cardona
PURPOSE OF REVIEW: The aim of the review is to describe the different clinical pictures of anaphylaxis (phenotypes), in relation to the underlying mechanisms and potential biomarkers, to describe anaphylaxis endotypes. This may aid in achieving a better understanding, management and outcomes of such severe reactions. RECENT FINDINGS: Different anaphylaxis phenotypes have been outlined, ranging from the classical type-I-like to those suggestive of cytokine-storm-like or complement-mediated reactions...
October 2018: Current Opinion in Allergy and Clinical Immunology
https://read.qxmd.com/read/29524997/exercise-lowers-threshold-and-increases-severity-but-wheat-dependent-exercise-induced-anaphylaxis-can-be-elicited-at-rest
#9
JOURNAL ARTICLE
Morten J Christensen, Esben Eller, Charlotte G Mortz, Knut Brockow, Carsten Bindslev-Jensen
BACKGROUND: Wheat-dependent, exercise-induced anaphylaxis (WDEIA) is a severe form of allergy in which exercise is being considered as mandatory. The diagnosis is often complex and the clinical reproducibility low. OBJECTIVE: The aims of this study were to establish a standardized challenge method for the diagnosis of WDEIA and to investigate whether exercise is an essential trigger factor or alternatively an augmentation factor able to lower threshold and increase severity...
March 2018: Journal of Allergy and Clinical Immunology in Practice
https://read.qxmd.com/read/29018449/mechanisms-cofactors-and-augmenting-factors-involved-in-anaphylaxis
#10
REVIEW
Rosa Muñoz-Cano, Mariona Pascal, Giovanna Araujo, M J Goikoetxea, Antonio L Valero, Cesar Picado, Joan Bartra
Anaphylaxis is an acute and life-threatening systemic reaction. Many triggers have been described, including food, drug, and hymenoptera allergens, which are the most frequently involved. The mechanisms described in anaphylactic reactions are complex and implicate a diversity of pathways. Some of these mechanisms may be key to the development of the anaphylactic reaction, while others may only modify its severity. Although specific IgE, mast cells, and basophils are considered the principal players in anaphylaxis, alternative mechanisms have been proposed in non-IgE anaphylactic reactions...
2017: Frontiers in Immunology
https://read.qxmd.com/read/28888247/fatal-anaphylaxis-mortality-rate-and-risk-factors
#11
REVIEW
Paul J Turner, Elina Jerschow, Thisanayagam Umasunthar, Robert Lin, Dianne E Campbell, Robert J Boyle
Up to 5% of the US population has suffered anaphylaxis. Fatal outcome is rare, such that even for people with known venom or food allergy, fatal anaphylaxis constitutes less than 1% of total mortality risk. The incidence of fatal anaphylaxis has not increased in line with hospital admissions for anaphylaxis. Fatal drug anaphylaxis may be increasing, but rates of fatal anaphylaxis to venom and food are stable. Risk factors for fatal anaphylaxis vary according to cause. For fatal drug anaphylaxis, previous cardiovascular morbidity and older age are risk factors, with beta-lactam antibiotics, general anesthetic agents, and radiocontrast injections the commonest triggers...
2017: Journal of Allergy and Clinical Immunology in Practice
https://read.qxmd.com/read/28780941/the-pathophysiology-of-anaphylaxis
#12
REVIEW
Laurent L Reber, Joseph D Hernandez, Stephen J Galli
Anaphylaxis is a severe systemic hypersensitivity reaction that is rapid in onset; characterized by life-threatening airway, breathing, and/or circulatory problems; and usually associated with skin and mucosal changes. Because it can be triggered in some persons by minute amounts of antigen (eg, certain foods or single insect stings), anaphylaxis can be considered the most aberrant example of an imbalance between the cost and benefit of an immune response. This review will describe current understanding of the immunopathogenesis and pathophysiology of anaphylaxis, focusing on the roles of IgE and IgG antibodies, immune effector cells, and mediators thought to contribute to examples of the disorder...
August 2017: Journal of Allergy and Clinical Immunology
https://read.qxmd.com/read/28780942/mast-cell-activation-syndromes
#13
REVIEW
Cem Akin
Mast cell activation is common and possibly necessary for maintenance of survival. Disordered mast cell activation occurs when mast cells are pathologically overproduced or if their activation is out of proportion to the perceived threat to homeostasis. Mast cell activation syndrome refers to a group of disorders with diverse causes presenting with episodic multisystem symptoms as the result of mast cell mediator release. Despite introduction of diagnostic criteria and some advances in treatment in the last decade, many areas of mast cell activation syndrome are in need of research...
August 2017: Journal of Allergy and Clinical Immunology
https://read.qxmd.com/read/28552379/are-ace-inhibitors-and-beta-blockers-dangerous-in-patients-at-risk-for-anaphylaxis
#14
REVIEW
Christopher A Coop, Rebecca S Schapira, Theodore M Freeman
The objective of this article is to review the available studies regarding angiotensin converting enzyme (ACE) inhibitors and beta-blockers and their effect on patients at risk for anaphylaxis. A literature search was conducted in PUBMED to identify peer-reviewed articles using the following keywords: anaphylaxis, ACE inhibitor, beta-blocker, food allergy, radiocontrast media, venom allergy, skin testing, and immunotherapy. Some studies show an increased risk of anaphylaxis in patients who are taking ACE inhibitors and beta-blockers, whereas others studies do not show an increased risk...
September 2017: Journal of Allergy and Clinical Immunology in Practice
https://read.qxmd.com/read/28302183/reaching-multidisciplinary-consensus-on-classification-of-anaphylaxis-for-the-eleventh-revision-of-the-world-health-organization-s-who-international-classification-of-diseases-icd-11
#15
JOURNAL ARTICLE
Luciana Kase Tanno, Robert J G Chalmers, Moises A Calderon, Ségolène Aymé, Pascal Demoly
BACKGROUND: Although currently misclassified in the International Classification of Diseases (ICD) and still not officially listed as a rare disease, anaphylaxis is a well-known clinical emergency. Anaphylaxis is now one of the principal headings in the "Allergic and hypersensitivity conditions" section recently compiled for the forthcoming 11th Revision of ICD (ICD-11). We here report the building process used for the pioneering "Anaphylaxis" subsection of ICD-11 in which we aimed for transparency as recommended in the ICD-11 revision guidelines...
March 16, 2017: Orphanet Journal of Rare Diseases
https://read.qxmd.com/read/28138352/anaphylaxis-in-a-4-year-old-male-caused-by-contact-with-grasses-a-case-report
#16
JOURNAL ARTICLE
Germán Darío Ramón, Victor H Croce, Iván Chérrez Ojeda
BACKGROUND: Acute urticaria is the presence of urticaria for <6 weeks, and it is the most common type of urticaria in children. Sometimes, it may be associated with anaphylaxis, a life-threatening condition. Urticaria must be differentiated from anaphylaxis because the latter may require emergency treatment. We describe a child with anaphylaxis exposed to grasses on two occasions. CASE PRESENTATION: We described a 4-year-old male child with anaphylaxis exposed to grasses...
2017: World Allergy Organization Journal
https://read.qxmd.com/read/27886904/mastocytosis-and-anaphylaxis
#17
REVIEW
Anna Schuch, Knut Brockow
This article updates current knowledge on epidemiology, risk factors, triggers, and management of anaphylaxis in patients with mastocytosis. Hyperactive mast cells and higher number of effector mast cells are speculated to facilitate anaphylaxis in this condition. In children, increased risk is limited to those with extensive skin involvement and high tryptase. In adults, manifestations of anaphylaxis are severe with high frequency of cardiovascular symptoms. Hymenoptera stings are the most common triggers for these reactions; however, idiopathic anaphylaxis and reactions to food or drugs occur...
February 2017: Immunology and Allergy Clinics of North America
https://read.qxmd.com/read/27864089/anaphylaxis-induced-by-ingested-molds
#18
JOURNAL ARTICLE
Ricardo Moreno-Borque, Teresa Collazo-Lorduy, Mariangélica Bermúdez-Martínez, Pilar Gajate-Fernández, Paula Sánchez-López, María Moreno-Geada, Nuria Plaza-Sánchez
No abstract text is available yet for this article.
January 2017: Annals of Allergy, Asthma & Immunology
https://read.qxmd.com/read/27822074/diagnosis-of-exercise-induced-anaphylaxis-current-insights
#19
REVIEW
Valerio Pravettoni, Cristoforo Incorvaia
Exercise-induced anaphylaxis (EIAn) is defined as the occurrence of anaphylactic symptoms (skin, respiratory, gastrointestinal, and cardiovascular symptoms) after physical activity. In about a third of cases, cofactors, such as food intake, temperature (warm or cold), and drugs (especially nonsteroidal anti-inflammatory drugs) can be identified. When the associated cofactor is food ingestion, the correct diagnosis is food-dependent EIAn (FDEIAn). The literature describes numerous reports of FDEIAn after intake of very different foods, from vegetables and nuts to meats and seafood...
2016: Journal of Asthma and Allergy
https://read.qxmd.com/read/27788890/rye-dependent-exercise-induced-anaphylaxis
#20
JOURNAL ARTICLE
Jesús Miguel García-Menaya, Gian Marco Chiarella, Concepción Cordobés-Durán, Alba Catherine Mahecha, Pedro Bobadilla-González
No abstract text is available yet for this article.
November 2016: Annals of Allergy, Asthma & Immunology
label_collection
label_collection
8093
1
2
2016-10-31 02:29:31
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.